Veru (VERU)

• Market cap: $36.9M
• 1 day: -3.77%
• 5 days: -6.5%
• 1 month: -48.08%
• 3 months: -34.84%
• 6 months: -54.9%
• Year to date: -64.72%
• 1 year: -63.2%
• 5 years: -92.43%
• 10 years: -85.44%
• Sector: Healthcare
• Industry: Biotechnology

About: Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

Employees: 210